Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04766801
Other study ID # 2007-06
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date January 1, 2008
Est. completion date December 31, 2030

Study information

Verified date February 2021
Source University Hospital, Angers
Contact Françoise Schmitt, MD-PhD
Phone 0241354290
Email FrSchmitt@chu-angers.fr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Obesity affects 3%-4% of the pediatric population and leads to cardiac mortality during adult life. Bariatric surgery is the best treatment for weight loss and preventing obesity associated comorbidities in adults, but its applications and safety are yet to be defined for adolescents.


Description:

Since 2008, in France, certain university hospitals have been eligible to perform bariatric surgery for adolescents. It was therfore possible to define its feasibility, potential complications and specific indications. This led to recommandations published by Health Authorities (HAS) in 2016. However, it seems imperative to continue monitoring these patients in order to improve their management, especially as the use of these surgical techniques becomes increasingly widespread. The Angers University Hospital is one of the leading hospitals when it comes bariatric surgery for adolescents through its use of gastric bands. The aim of this protocol is to update data on how effective this surgery is on weight loss and obesity-associated comorbidities, and to monitor medical, psychological and surgical complications associated with this treatment.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date December 31, 2030
Est. primary completion date October 31, 2021
Accepts healthy volunteers No
Gender All
Age group 14 Years to 20 Years
Eligibility Inclusion Criteria: - Patients aged 14-20 years of age and asking for bariatric surgery - BMI >= 40 Kg.m-2 or >= 35 Kg.m-2 with major obesity-related comorbidities (hypertension, diabetes, sleep apnea, etc...) Exclusion Criteria: - An unstable psychiatric disorder - Bariatric surgery anesthesic contraindications - Having not completed a minimum of six months of the pre operative program - Lack of consent from the patient or the patient's relatives.

Study Design


Intervention

Procedure:
Laparoscopic adjustable gastric banding
Weight-loss surgery, with the use of gastric banding

Locations

Country Name City State
France University Hospital of Angers Angers Maine Et Loire

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Angers

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change of weight parameters at 2 years compared to preoperative baseline Evaluation of weight loss by weight (Kg), body mass index (BMI, Kg.m-2) and excess body weight (EBWL, %) changes 2 years
Secondary Changes of insulin resistance at 2 years Evaluation of insulin resistance by measure of the HOMA index 2 years
Secondary Evaluation of dyslipidemia Evaluation of lipid profile (cholesterol, triglycerides) 2 years
Secondary Evaluation of liver steatosis Evaluation of liver steatosis and NAFLD on US exam and liver elastometry 2 years
Secondary Resolution of comorbidities associated with obesity Clinical evaluation of the presence/absence of hypertension, sleep apnea, orthopedic disorders and polycystic ovary at two years, compared to Baseline characteristics 2 years
Secondary Monitoring of psychiatric profile Clinical evaluation of the presence/absence of psychiatric disorders such as binge eating, depression, etc... 2 years
Secondary Evaluation of quality of life Evaluation of obesity-related QOL by the use of the PedsQL scale 2 years
Secondary Evaluation of cosmetic satisfaction Evaluation of the patient's level of satisfaction with regards to their surgical scar using the POSAS scale 12 months postoperative
Secondary Surgical complications Monitoring of the occurrence of surgical complications and their severity thanks to the Clavien-Dindo scale at each medical consultation 2 years
See also
  Status Clinical Trial Phase
Recruiting NCT05650307 - CV Imaging of Metabolic Interventions
Not yet recruiting NCT05536466 - The Influence of Having Bariatric Surgery on the Pharmacokinetics, Safety and Efficacy of the Novel Non-nucleoside Reverse Transcriptase Inhibitor Doravirine N/A
Active, not recruiting NCT04583683 - Effects of Very Low Calorie Diet vs Metabolic Surgery on Weight Loss and Obesity Comorbidities N/A
Completed NCT04099654 - The Effect of Core Stabilization Exercise Program in Obese Subjects Awaiting Bariatric Surgery N/A
Completed NCT03809182 - Effect of Dexmedetomidine on Postoperative Glucose and Insulin Levels. Phase 4
Completed NCT03638843 - Endoscopic Gastric Mucosal Devitalization (GMD) as a Primary Obesity Therapy - Part 2 N/A
Withdrawn NCT05845359 - Intraoperative Methadone for Postoperative Pain Control Phase 4
Not yet recruiting NCT04343040 - Perioperative Evaluation of Glucose Profile Using Continuous Glucose Monitoring System in Glucose Intolerant Patients N/A
Withdrawn NCT03095404 - Intravenous Lidocaine for Post-Operative Pain Control in Patients Undergoing Bariatric Bowel Surgery Early Phase 1
Recruiting NCT03100292 - Korean OBEsity Surgical Treatment Study N/A
Active, not recruiting NCT04357119 - Common Limb Length in One-anastomosis Gastric Bypass N/A
Completed NCT04883268 - Focusing on Body Functionality After Bariatric Surgery N/A
Completed NCT03210207 - Gastric Plication in Mexican Patients N/A
Completed NCT02300168 - Neuromuscular Blockade: Outcome and Recovery for Laparoscopic Bariatric Surgery N/A
Unknown status NCT01264120 - The Impact of a Bariatric Rehabilitation Service on Patient Outcomes N/A
Recruiting NCT03972319 - Omega-3 Supplementation for LIver VolumE Reduction Study (OLIVER) Study Early Phase 1
Terminated NCT04626232 - Comparison of the Sleeve Gastrectomy Technique With a Nissen Fundoplication Added to the Conventional Sleeve Gastrectomy Technique in Morbidly Obese Patients N/A
Completed NCT03643783 - Impact of Plasma Soluble Prorenin Receptor in Obese and Type 2 Diabetic Patients
Completed NCT04219852 - Contraception and Bariatric Surgery: Evaluation of Contraception and Contraceptive Knowledge of Women Undergoing Bariatric Surgery at the University Hospital of Reims
Recruiting NCT05570474 - Effect of Protein Supplementation on Fat Free Mass Preservation After Bariatric Surgery N/A